Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Bausch Health Companies, Inc.: Mephyton and Phytonadione Tablets Recalled for Impurity Specifications

Agency Publication Date: June 23, 2021
Share:
Sign in to monitor this recall

Summary

Bausch Health Companies, Inc. is recalling approximately 40,488 bottles of Mephyton (phytonadione) and generic Phytonadione 5 mg tablets because the products failed to meet specifications for impurities and degradation. This recall affects 2,691 bottles of Mephyton 100-count tablets and 37,797 bottles of Phytonadione 30-count tablets sold nationwide. Consumers using these medications should be aware that the product may contain levels of impurities that do not meet the company's quality standards.

Risk

The tablets failed to meet the required quality specifications for impurities and degradation over time, which may affect the chemical stability or purity of the medication. No specific injuries or adverse health events have been reported in the provided data.

What You Should Do

  1. Check your medication bottles for Mephyton (Phytonadione) 5 mg 100-count tablets with NDC 0187-1704-05 and look for Lot 19D012P (Exp 07/2021) or Lot 20D096P (Exp 10/2022).
  2. Check your medication bottles for Phytonadione 5 mg 30-count tablets with NDC 68682-170-30 and look for Lot 19D013P (Exp 07/2021) or Lot 20D099P (Exp 10/2022).
  3. Contact your healthcare provider or pharmacist immediately to discuss your treatment and to obtain a replacement prescription before you stop taking the medication.
  4. Return any unused tablets from the affected lots to your pharmacy for a refund and further instructions on how to dispose of the product safely.
  5. Contact the manufacturer, Bausch Health Companies, Inc., at their Bridgewater, NJ headquarters if you have specific questions regarding this voluntary recall.
  6. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Mephyton (Phytonadione) 5 mg tablets (100-count)
Model:
NDC 0187-1704-05
Lot Numbers:
19D012P (Exp Date 07/2021)
20D096P (Exp Date 10/2022)
Date Ranges: 07/2021, 10/2022
Product: Phytonadione Tablets, 5 mg (30-count)
Model:
NDC 68682-170-30
Lot Numbers:
19D013P (Exp Date 07/2021)
20D099P (Exp Date 10/2022)
Date Ranges: 07/2021, 10/2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88079
Status: Resolved
Manufacturer: Bausch Health Companies, Inc.
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 2 products (2,691 bottles; 37,797 bottles)
Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.